Target intelligence / Profile preview

Non-specific gastrointestinal contents

Molecular classification
Other
01

Overview

Non-specific gastrointestinal contents represent the diverse array of substances found within the lumen of the digestive tract, including ingested food, drugs, toxins, and endogenous secretions (DrugBank, DB09278). In pharmacology, this target is primarily addressed by adsorbent medications that do not bind to specific biological receptors but rather interact with the bulk contents of the gut through physical means (StatPearls, NBK482294). The primary mechanism involved is physical adsorption, where substances are held on the surface of the adsorbent through intermolecular forces like Van der Waals interactions (PubChem, CID 104757). This interaction is crucial in the clinical management of acute toxic ingestions and drug overdoses, as it prevents the systemic absorption of harmful agents into the bloodstream. Beyond toxicology, targeting these contents can help manage symptoms of diarrhea by binding excess water, bacterial toxins, or irritants. However, because the adsorption is non-specific, these treatments can also interfere with the absorption of essential nutrients and other therapeutic medications. Safety concerns include the risk of bowel obstruction and potential aspiration if the adsorbent is administered improperly, particularly in patients with a compromised airway. Overall, this target is unique because its therapeutic utility relies on physical chemistry rather than traditional biochemical signaling pathways.

Other names
Gastrointestinal contentsGastric contentsIntestinal lumen contentsGastrointestinal toxicantsIntestinal toxins
02

Mechanism of action

Physical adsorption of molecules (toxins, drugs, or fluids) onto the surface of an adsorbent agent within the gastrointestinal lumen to prevent their systemic absorption or to alter stool consistency.

03

Biological functions

Other
04

Disease associations

InfectionOther
05

Safety considerations

Gastrointestinal obstructionReduced absorption of therapeutic medicationsAspiration pneumonitisConstipationFecal impaction
06

Interacting drugs

Activated charcoal

4 more in the full profile.

07

Biomarkers

Serum toxin concentrationBlood drug levelsStool consistency

Beyond the preview

Go deeper on Non-specific gastrointestinal contents.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-specific gastrointestinal contents.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call